Treatment of Chemotherapy-Induced Thrombotic Microangiopathy with Eculizumab in a Patient with Metastatic Breast Cancer

The unexpected occurrence of thrombotic microangiopathy (TMA), characterised by microangiopathic haemolytic anaemia and thrombocytopenia, in a patient with cancer requires urgent diagnosis and appropriate management. TMA in patients with metastatic cancer can be a manifestation of the malignancy its...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Martin Hausberg, Helmut Felten, Stefan Pfeffer
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Karger Publishers 2019-01-01
Edice:	Case Reports in Oncology
Témata:	aHUS Atypical Haemolytic Syndrome Bevacizumab Breast cancer Complement Eculizumab Metastases Mitomycin Thrombotic microangiopathy
On-line přístup:	https://www.karger.com/Article/FullText/495031
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!